[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Google Scholar Metrics

Citation Indices from GS

AllSince 2018

Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Registered in



:: Volume 25, Issue 4 (11-2017) ::
Journal of Ilam University of Medical Sciences 2017, 25(4): 1-12 Back to browse issues page
Investigating the Most Expensive Prescribed Items in the Prescriptions of Treatment Office of the Insured of Health Insurance Organization in 2014 and 2015
Morad Nasri *1, Ali Shojaee2
1- Health Insurance Ilam Province, Ilam, Iran , morad_nasry@yahoo.com
2- Health Insurance Tehran Province. Tehran, Iran
Abstract:   (6361 Views)

Introduction: Today, medicine is a strategic commodity that has a significant share of total household expenditure baskets and plays a role in the economy and the health of the family and society. Recognizing the pharmaceutical costs and its analysis help to optimize the pharmaceutical costs.
Materials & methods: The statistical population of the study included existing data on 61 million prescriptions in 2014 and 69 million prescriptions of insured of the Health Insurance Organization in 2015 that was sent by the pharmacy to departments of health insurance. Using existing records in the database and health insurance processor, data received from different provinces were analyzed by census method and using the software Excel 2007 and SPSS21, and results were extracted.
Findings: 80% of pharmaceutical costs in 2014 was used by 9.84% and in 2015 is consumed by the 8.87% of items. In 2014, drugs like interferon, insulin, Herceptin, cefixime, growth hormone, mycophenolate mofetil, Avastin, atorvastatin, Cytotoxic Mab and Tryptorlin, and in 2015, insulin, interferon, Herceptin, Avastin, cefixime, growth hormone, Factor 8, mycophenolatemofetil, atorvastatin and enoxaparin, were 10 expensive drugs to the country, respectively. In 2014 pharmaceutical groups of anti-neoplasm, anti-MS, antibiotics, antidiabetic, analgesics, immunosuppressive, growth, antihypertensives, bronchodilators and lipid lowering and in 2015 anti-neoplastic, antibiotic, anti-diabetic, anti-MS, analgesics, immunosuppressive, anti-hemophilia, blood pressure, growth and bronchodilator, were10 groups costly to the country,respectively.
Discussion & conclusions: Monitoring and control 10% of Pharmaceutics items can optimize 80% of pharmaceutical costs of organizations and have a considerable impact on the economy of the medicine of the country's pharmaceutical costs and medication economy.

Keywords: Pharmaceutics items, Pharmaceutics group, The Insured, Health insurance, Cost
Full-Text [PDF 593 kb]   (1720 Downloads)    
Type of Study: Applicable |
Received: 2016/12/31 | Accepted: 2017/06/20 | Published: 2017/10/30
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nasri M, Shojaee A. Investigating the Most Expensive Prescribed Items in the Prescriptions of Treatment Office of the Insured of Health Insurance Organization in 2014 and 2015. J. Ilam Uni. Med. Sci. 2017; 25 (4) :1-12
URL: http://sjimu.medilam.ac.ir/article-1-4036-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 4 (11-2017) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.15 seconds with 40 queries by YEKTAWEB 4613